🔎 Consulta tota l'anàlisi sobre el creixement empresarial a l'Informe de la BioRegió: https://informe.biocat.cat/
#BioRegionReport #HealthInnovation

Un ecosistema viu que evoluciona cap a la innovació estratègica i la maduresa global. 📈

🔹Les spinoffs guanyen pes estratègic i ja suposen el 26% de les noves companyies, clau per transformar la recerca en actius de mercat.
🔹De les empreses creades en l'última dècada, un 73% segueixen operatives, cosa que reflecteix la maduració i resiliència del teixit.

🔹El subsector biotec es confirma com el pilar més estable de l'ecosistema i ja representa el 29% del total de noves empreses.
🔹El segment digital health és el més actiu en obertures (34%), tot i que registra una major rotació per la complexitat d'escalar els models de negoci.

Catalunya no només crea empreses, sinó que consolida un teixit resilient on el balanç net continua sent positiu malgrat la rotació natural del sector.

🔹El sector manté un ritme constant de creixement amb 639 startups creades des de 2016, de les quals 464 continuen actives.

🚀 Dinamisme i evolució del teixit emprenedor a la BioRegió

En el marc del #DiaMundialDeLEmprenedoria, l'Informe de la BioRegió destaca la solidesa d'un ecosistema que manté un ritme constant de creixement amb més d'una nova empresa a la setmana.

A contribution that reinforces the BioRegion’s position in major European debates on science policy and biotechnology competitiveness.

particularly regarding coordination with clinical trial authorisations and incentives to keep research and production in Europe.

She also stressed the importance of better defining these mechanisms to ensure the regulation translates into real impact on the European IS.

In her contribution, she highlighted a key aspect of the new regulation, noting that “there is a missing layer on how it connects with other policy files and how it will actually be implemented,”

🌍 The voice of the BioRegion in the European debate on the Biotech Act

Montserrat Daban took part in a POLITICO feature within the analysis promoted by EIT Health on the future European Biotech Act.

HLTh Europe 2026

Don’t miss this unique opportunity to place your project at the heart of Europe’s healthcare transformation.

Register now👉

✔️Use the virtual platform to schedule 1:1 meetings with top-tier investors and strategic partners before the event starts.
✔️ Showcase your healthtech solutions at HLTH Europe, where one in three attendees are executives

📌 Advantages for BioRegion companies:
✔️Get an exclusive €250 discount for companies and organizations in the BioRegion of Catalonia using code HE26_BIOCAT250.

Are you ready for Europe’s #1 health innovation event? From June 15 to 18, the RAI Convention Centre in Amsterdam will host HLTH Europe 2026, bringing together over 5,000 leaders and decision-makers from across the healthcare landscape.

🌍 HLTH Europe 2026: Connect with the future of healthcare in Amsterdam

PRECISEU launches €11.57 million call for proposals for innovation projects in personalized medicine | Biocat The call, open from April 13 to June 14, 2026, will fund interregional innovation projects and companies in advanced therapies and use of health data to drive development of solutions with technology readiness level between TRL 6 and TRL 8.

In Catalonia, the participating funding entities are the Departament de Salut of the @gencat and ACCIÓ.

Register for the informational webinar on April 14 and prepare your proposal 👉 www.biocat.cat/en/current-news/news/pre...

#PRECISEU

The call is aimed at international consortia (companies, research centers, hospitals, universities, etc.) looking to take innovation one step further and generate a real impact on personalized medicine.

📅 Call open from April 13 to June 14, 2026
💰 Up to €3M per project (maximum €600k per entity)
🔬 Projects in TRL 6–8 stages with a clear path to market

💡 New PRECISEU Open Call: €11.57M to boost personalized medicine
The new PRECISEU call is now open to fund innovation projects in advanced therapies and health data, aiming to accelerate the market entry of new solutions.

Job board Looking for a job? The Biocat job listings is the benchmark platform in the life sciences and healthcare sector in Catalonia. Here you will find job offers and internships in the health, biotechnology, medical technology, digital health and related sectors from companies and research bodies in the B...

🚀 Find your next career move in the BioRegion of Catalonia, where science, innovation, and talent converge.

🔹 Software Coordinator (Earth Sciences Department) – Barcelona Supercomputing Center
🔹 Tècnic/a Senior de Recerca i Innovació – Hospital General de Granollers
🔹 Group Leader: Chemical and Structural Biology – IRB Barcelona

🔹 Gestor/a de Centres de Recerca – Fundació ”la Caixa”
🔹 Project Manager de Projectes Europeus – Biocat

💼 Top job opportunities in the #BioRegion of Catalonia

Discover new professional challenges in one of Europe’s most dynamic health and life sciences ecosystems:

ATMP Catalyst ATMP Catalyst supports early-stage projects and startups in advanced therapies through a structured three-year program. It offers expert mentoring and training, regulatory guidance, access to equipped lab spaces, and connections with key industry players. By linking participants with investors, hospitals, and CDMOs, it accelerates their path to clinical trials and market entry.

👉 Apply now: https://www.biocat.cat/en/programs/atmpcatalyst

#ATMPCatalyst #HealthInnovation #AdvancedTherapies

With the support of: Departament de Recerca i Universitats, Ajuntament de Barcelona, eatris, iese Leitat, Parc Científic de Barcelona, SID Barcelona and Cosymbio Labs

💡 Who should apply? TRL 2–3 projects and startups in advanced therapies with strong translational potential and ambition to reach patients.

🚀 Join one of the leading accelerator programmes for advanced therapies projects in Europe and take your innovation to the next level.

📅 Kick-off: 11 June 2025
📍 Locations: Leitat, Parc Científic de Barcelona, SID & Cosymbio
💰 Free programme (mentoring, training & regulatory support) + subsidised lab spaces

From science to clinical impact, selected teams will access expert mentoring, specialised training, regulatory guidance, and direct connections with investors, hospitals and CDMOs, accelerating their path towards clinical trials and market entry.

🧬 ATMP Catalyst call for applications is now open

ATMP Catalyst is a three-year acceleration programme designed to boost health innovation and support early-stage advanced therapies projects and startups across the BioRegion of Catalonia.

Mapatge d’instruments i serveis disponibles En el marc del Programa d'Accés de la innovació al Sistema de Salut de Catalunya (PASS) de Catalunya, Biocat ha elaborat un catàleg de tots els instruments, programes i recursos disponibles a l’ecosistema, adreçats a la comunitat innovadora en salut, anomenat Navegador.Aquesta eina, permet filtrar per diferents opcions i trobar aquells programes i serveis que responguin als teus interessos i necessitats, en funció de la fase de desenvolupament i del tipus de tecnologia del teu projecte.

🚀 The goal is to streamline the adoption of innovation and better connect projects with the healthcare system.

Access the Navigator and find the support you need 👉

This tool allows you to filter resources based on project phase and technology type, facilitating access to funding, acceleration, and technological and clinical validation.